Marco Salvetti

Pubblicazioni

Titolo Pubblicato in Anno
IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism CELL DEATH & DISEASE 2019
Genome-Wide Multiple Sclerosis Association Data and Coagulation FRONTIERS IN NEUROLOGY 2019
A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in multiple sclerosis JOURNAL OF AUTOIMMUNITY 2019
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority FRONTIERS IN NEUROLOGY 2019
The contribution of gut barrier changes to multiple sclerosis pathophysiology FRONTIERS IN IMMUNOLOGY 2019
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study JOURNAL OF NEUROLOGY 2019
Autoimmune encephalitis and CSF anti-glur3 antibodies in an MS patient after alemtuzumab treatment BRAIN SCIENCES 2019
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register JOURNAL OF NEUROLOGY 2019
The Italian multiple sclerosis register NEUROLOGICAL SCIENCES 2019
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility SCIENCE 2019
Conversion to secondary progressive multiple sclerosis: patient awareness and needs. Results from an online survey in Italy and Germany FRONTIERS IN NEUROLOGY 2019
Brain fibrinogen deposition plays a key role in MS pathophysiology. Commentary MULTIPLE SCLEROSIS 2019
La neurologia della Sapienza 2019
Intestinal Permeabiliy in Relapsing-Remitting Multiple Sclerosis NEUROTHERAPEUTICS 2018
Validating Nonlinear Registration to Improve Subtraction Images for Lesion Detection and Quantification in Multiple Sclerosis JOURNAL OF NEUROIMAGING 2018
Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia CLINICAL NEUROLOGY AND NEUROSURGERY 2018
Fingolimod vs dimethyl fumarate in multiple sclerosis. a real-world propensity score-matched study NEUROLOGY 2018
Author correction. Transcriptional dysregulation of interferome in experimental and human multiple sclerosis SCIENTIFIC REPORTS 2018
Steps towards collective sustainability in biomedical research TRENDS IN MOLECULAR MEDICINE 2018
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND). a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension LANCET NEUROLOGY 2018

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma